Mathieu Minsat
Overview
Explore the profile of Mathieu Minsat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
239
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Graff P, Pommier P, Minsat M, Crehange G
Cancer Radiother
. 2024 Oct;
28(6-7):513-518.
PMID: 39384514
Herein, we provide a non-exhaustive selection of the main clinical trials presented in 2023-2024 related to radiation-oncology used in the treatment of urological cancers including prostate cancer (radiotherapy of localized...
2.
Rodrigues M, Vanoni G, Loap P, Dubot C, Timperi E, Minsat M, et al.
Nat Commun
. 2023 Jun;
14(1):3698.
PMID: 37349318
Concurrent chemoradiotherapy (CRT) with blockade of the PD-1 pathway may enhance immune-mediated tumor control through increased phagocytosis, cell death, and antigen presentation. The NiCOL phase 1 trial (NCT03298893) is designed...
3.
Vendrely V, Ronchin P, Minsat M, Le Malicot K, Lemanski C, Mirabel X, et al.
Radiother Oncol
. 2023 Jun;
186:109742.
PMID: 37315583
Background And Purpose: Standard treatment of squamous cell carcinoma of the anus (SCCA)is 5-fluorouracil (5FU) and mitomycin C (MMC) based chemoradiotherapy (CRT). This phase II study (EudraCT: 2011-005436-26) assessed the...
4.
Vendrely V, Lemanski C, Pommier P, Le Malicot K, Saint A, Rivin Del Campo E, et al.
Radiother Oncol
. 2023 Feb;
183:109542.
PMID: 36813175
Introduction: International guidelines regarding the treatment of squamous cell carcinoma of the anus (SCCA) recommend intensity-modulated radiotherapy (IMRT) combined with mitomycin-based chemotherapy (CT). The French FFCD-ANABASE cohort aimed at evaluating...
5.
Porte J, Saint-Martin C, Frederic-Moreau T, Massiani M, Bozec L, Cao K, et al.
Biomedicines
. 2022 Sep;
10(9).
PMID: 36140349
Background: To analyze the outcomes of patients with brain metastases (BM) from non-small cell lung cancer (NSCLC) treated with immunotherapy (IT) and stereotactic radiotherapy (SRT) and to study the impact...
6.
Beddok A, Calugaru V, De Marzi L, Graff P, Dumas J, Goudjil F, et al.
Crit Rev Oncol Hematol
. 2022 Apr;
174:103655.
PMID: 35398521
Since the development of new radiotherapy techniques that have improved healthy tissue sparing, reirradiation (reRT) has become possible. The selection of patients eligible for reRT is complex given that it...
7.
Beddok A, Chevrier M, Calugaru V, Minsat M, Dendale R, Lantz O, et al.
Int J Radiat Biol
. 2021 Jul;
97(10):1436-1440.
PMID: 34269644
Purpose: This study aimed to assess the risk of acute and late radiation-induced toxicity in patients with COVID-19. Material And Methods: All the patients irradiated in Institut Curie from March...
8.
Scholl S, Popovic M, De la Rochefordiere A, Girard E, Dureau S, Mandic A, et al.
EBioMedicine
. 2020 Jul;
57:102875.
PMID: 32650273
No abstract available.
9.
Beddok A, Calugaru V, Minsat M, Dendale R, De Oliveira A, Costa E, et al.
Radiother Oncol
. 2020 Jun;
150:12-14.
PMID: 32512077
No abstract available.
10.
Cagetti L, Zemmour C, Minsat M, Lambaudie E, Houvenaeghel G, Provansal M, et al.
Gynecol Oncol
. 2019 Dec;
156(2):328-334.
PMID: 31864683
Purpose: To analyze the clinical outcomes and the safety of radiochemotherapy (RCT) and image-guided adaptive brachytherapy (IGABT) and to evaluate the impact of hysterectomy (HT) as completion of treatment for...